DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, Johansen OE, Woerle HJ, Broedl UC, Zinman B. Investigators e-ro.
empagliflozin and progression of kidney disease in type 2 diabetes.
N Engl J Med 2016;
375: 323-334
We do not assume any responsibility for the contents of the web pages of other providers.